FBXO22 mediates the NGF/TRKA signaling pathway in bone metastases in prostate cancer. Zhang Y, Li W, Guo S, Wu Z, et al. Am J Pathol 2023 Jun 8:S0002-9440(23)00204-3. doi: 10.1016/j.ajpath.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Zhang Y, Li W, Guo S, Wu Z, et al. FBXO22 mediates the NGF/TRKA signaling pathway in bone metastases in prostate cancer. Am J Pathol 2023 Jun 8:S0002-9440(23)00204-3. doi: 10.1016/j.ajpath.2023.
PMID: 37301536